Detalhe da pesquisa
1.
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Circulation
; 148(2): 124-134, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212600
2.
Clinical trajectory of patients with a worsening heart failure event and reduced ventricular ejection fraction.
Am Heart J
; 245: 110-116, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932997
3.
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure-Reply.
JAMA
; 329(19): 1704, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191705
4.
Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: A randomized intervention in high-risk patients.
Am Heart J
; 169(4): 539-48, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819861
5.
Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease.
Europace
; 16(9): 1284-90, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24755440
6.
The pharmacology of novel oral anticoagulants.
J Thromb Thrombolysis
; 37(2): 217-33, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-23860880
7.
Management of Heart Failure With Reduced Ejection Fraction.
Curr Probl Cardiol
; 48(5): 101596, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681212
8.
Patients hospitalized with acute heart failure, worsening renal function, and persistent congestion are at high risk for adverse outcomes despite current medical therapy.
Clin Cardiol
; 46(10): 1163-1172, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37464579
9.
Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients.
Am J Cardiol
; 186: 91-99, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371856
10.
An evaluation of torsemide in patients with heart failure and renal disease.
Expert Rev Cardiovasc Ther
; 20(1): 5-11, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936522
11.
Body surface area and medication dosing in patients with heart failure with reduced ejection fraction.
Trends Cardiovasc Med
; 31(2): 111-116, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32008834
12.
Anticoagulants: Pharmacokinetics, Mechanisms of Action, and Indications.
Neurosurg Clin N Am
; 29(4): 503-515, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30223963
13.
Achieving a Maximally Tolerated ß-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?
J Am Coll Cardiol
; 69(20): 2542-2550, 2017 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28521892
14.
Cardiohepatic interactions in heart failure: an overview and clinical implications.
J Am Coll Cardiol
; 61(24): 2397-2405, 2013 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23603231
15.
Pharmacotherapy in Medicare beneficiaries with atrial fibrillation.
Heart Rhythm
; 9(9): 1403-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22537885
16.
Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
Expert Rev Cardiovasc Ther
; 8(2): 159-69, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20136602
17.
Combination of loop diuretics with thiazide-type diuretics in heart failure.
J Am Coll Cardiol
; 56(19): 1527-34, 2010 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21029871
18.
Uso de agentes antiarrítmicos y resultados clínicos en pacientes añosos con fibrilación auricular y enfermedad coronaria concomitante
Rev. urug. cardiol
; 30(1): 89-98, abr. 2015. graf, tab
Artigo
em Espanhol
|
LILACS-Express
| ID: lil-754348